Abstract Helmet CPAP (H-CPAP) has been recommended in many guidelines as a
noninvasive respiratory support during COVID-19 pandemic in many countries around the …

Introduction Hospitalised patients with coronavirus disease 2019 (COVID-19) as a result of
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have a high …

Background Respiratory failure due to COVID-19 pneumonia is associated with high
mortality and may overwhelm health care systems, due to the surge of patients requiring …

The coronavirus disease 2019 (COVID-19) pandemic has prompted a rapid and
unprecedented reorganization of medical institutions, affecting clinical care for patients with …

A few months after the description of the first case of COVID-19 in China, the disease
became a pandemic. More than 50 million people have been infected with SARS-CoV-2 …

Patients with SARS-CoV generally require noninvasive treatments including continuous
positive airway pressure (CPAP), and appropriate nutritional therapy. Our hypothesis was …

Poucos meses depois da descrição do primeiro caso na China, a COVID-19 tornou-se
pandêmica. Mais de 50 milhões de pessoas foram contaminadas pelo vírus e, até o …

During the COVID-19 pandemic, the use of non-invasive respiratory support (NIRS) became
crucial in treating patients with acute hypoxemic respiratory failure. Despite the fear of viral …

Approximately 15 to 20% of COVID-19 cases develop acute hypoxemic respiratory failure
(AHRF) requiring oxygen therapy and ventilatory support. Noninvasive strategies to avoid …

We are grateful to Professor Morice for his reminder of the limits of observational data, and
the need for caution in its interpretation [1]. And we accept that it is unlikely to ever be proved …